Showing results (171-180 of 193) with videos related to
Sort By:
Pageof 20
International Journal of Epidemiology|April 12, 2012
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration, Charlotte Lewden, Vincent Bouteloup, et al.Plos One|April 6, 2017
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllersFanny Chereau, Yoann Madec, Caroline Sabin, et al.The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013, Amanda Mocroft, Jens Lundgren, et al.Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.Pageof 20